UroGen Pharma
URGN
URGN
41 hedge funds and large institutions have $254M invested in UroGen Pharma in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
32% more funds holding
Funds holding: 31 → 41 (+10)
16.73% more ownership
Funds ownership: 35.14% → 51.88% (+17%)
Holders
41
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$35M | |
| 2 | +$34.1M | |
| 3 | +$8.55M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$4.61M |
| 5 |
Renaissance Technologies
New York
|
+$3.93M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$4.68M | |
| 3 | -$2.95M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.6M |
| 5 |
BII
Bainco International Investors
Boston,
Massachusetts
|
-$2.28M |